ZA200300514B - Novel compounds and their use as glycine transport inhibitors. - Google Patents

Novel compounds and their use as glycine transport inhibitors. Download PDF

Info

Publication number
ZA200300514B
ZA200300514B ZA200300514A ZA200300514A ZA200300514B ZA 200300514 B ZA200300514 B ZA 200300514B ZA 200300514 A ZA200300514 A ZA 200300514A ZA 200300514 A ZA200300514 A ZA 200300514A ZA 200300514 B ZA200300514 B ZA 200300514B
Authority
ZA
South Africa
Prior art keywords
phenyl
propyl
chloro
methyl
dihydro
Prior art date
Application number
ZA200300514A
Other languages
English (en)
Inventor
Ejner Knud Moltzen
Garrick Paul Smith
Christian Krog-Jensen
Klaus Peter Bogeso
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of ZA200300514B publication Critical patent/ZA200300514B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200300514A 2000-07-21 2003-01-20 Novel compounds and their use as glycine transport inhibitors. ZA200300514B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200001124 2000-07-21

Publications (1)

Publication Number Publication Date
ZA200300514B true ZA200300514B (en) 2004-08-20

Family

ID=8159626

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200300514A ZA200300514B (en) 2000-07-21 2003-01-20 Novel compounds and their use as glycine transport inhibitors.

Country Status (28)

Country Link
US (1) US6921774B2 (ja)
EP (1) EP1301502B1 (ja)
JP (1) JP2004504393A (ja)
KR (1) KR20030015889A (ja)
CN (1) CN100509791C (ja)
AR (1) AR032358A1 (ja)
AT (1) ATE295844T1 (ja)
AU (2) AU2001281740B2 (ja)
BG (1) BG107530A (ja)
BR (1) BR0113011A (ja)
CA (1) CA2416447A1 (ja)
CZ (1) CZ2003396A3 (ja)
DE (1) DE60110914T2 (ja)
EA (1) EA005621B1 (ja)
ES (1) ES2238466T3 (ja)
HR (1) HRP20030053A2 (ja)
HU (1) HUP0302778A3 (ja)
IL (2) IL153988A0 (ja)
IS (1) IS6693A (ja)
MX (1) MXPA03000642A (ja)
NO (1) NO20030243L (ja)
NZ (1) NZ523720A (ja)
PL (1) PL364439A1 (ja)
PT (1) PT1301502E (ja)
SK (1) SK2022003A3 (ja)
UA (1) UA75081C2 (ja)
WO (1) WO2002008216A1 (ja)
ZA (1) ZA200300514B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100439330C (zh) * 2003-04-30 2008-12-03 H.隆德贝克有限公司 芳族羟苯基和芳族硫基苯基衍生物
MXPA06002002A (es) * 2003-08-21 2006-05-17 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y un inhibidor de transportador de glicina tipo 1 para el tratamiento de depresion.
US7163954B2 (en) * 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
WO2005087708A1 (en) * 2004-03-12 2005-09-22 H. Lundbeck A/S Phenyl indan derivatives
WO2005100301A1 (en) * 2004-03-31 2005-10-27 Eli Lilly And Company 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
WO2006000222A2 (en) * 2004-06-24 2006-01-05 H. Lundbeck A/S The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia
KR101389209B1 (ko) * 2006-07-18 2014-04-24 아스텔라스세이야쿠 가부시키가이샤 아미노인단 유도체 또는 그의 염
BRPI0715729A2 (pt) * 2006-08-30 2013-09-24 Hoffmann La Roche inibidores para glyt-1
US20100083581A1 (en) * 2007-06-18 2010-04-08 Mattice Douglas A Environmental brush seal
EP3006023B1 (en) 2009-01-20 2019-06-26 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Sorbic acid and derivatives thereof to enhance the activity of a neuropharmaceutical
EP2380595A1 (en) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
US9700563B2 (en) * 2012-09-06 2017-07-11 MediSynergies, LLC Kappa opioid receptor compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1166711A (en) * 1966-03-28 1969-10-08 Kefalas As Process for the Preparation of Phenyl-Indane and -Tetralin Derivatives
US3549656A (en) 1967-12-28 1970-12-22 Kefalas As Antidepressant 1 - aminoalkyl - thiophthalanes and acid addition salts thereof
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US5225323A (en) 1988-11-21 1993-07-06 Baylor College Of Medicine Human high-affinity neurotransmitter uptake system
EP0614487A4 (en) 1991-11-12 1995-04-19 Synaptic Pharma Corp AND CODING A GLYCINE CONVEYOR AND ITS USES.
US5824486A (en) 1996-05-31 1998-10-20 Allelix Neuroscience Inc. Glycine transporter-transfected cells and uses thereof
US6008015A (en) 1997-04-11 1999-12-28 Allelix Neuroscience Inc. Glycine transporter
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6566550B2 (en) * 2001-06-21 2003-05-20 Pfizer Inc Substituted aromatic ethers as inhibitors of glycine transport

Also Published As

Publication number Publication date
EP1301502B1 (en) 2005-05-18
ATE295844T1 (de) 2005-06-15
AU8174001A (en) 2002-02-05
EA005621B1 (ru) 2005-04-28
JP2004504393A (ja) 2004-02-12
AU2001281740B2 (en) 2006-02-16
US6921774B2 (en) 2005-07-26
SK2022003A3 (en) 2003-06-03
NZ523720A (en) 2004-07-30
US20030181445A1 (en) 2003-09-25
DE60110914T2 (de) 2005-10-27
ES2238466T3 (es) 2005-09-01
EP1301502A1 (en) 2003-04-16
KR20030015889A (ko) 2003-02-25
UA75081C2 (en) 2006-03-15
MXPA03000642A (es) 2003-06-06
NO20030243L (no) 2003-03-06
CN100509791C (zh) 2009-07-08
BG107530A (bg) 2003-09-30
IL153988A (en) 2006-10-05
CA2416447A1 (en) 2002-01-31
HUP0302778A2 (hu) 2003-12-29
WO2002008216A1 (en) 2002-01-31
HRP20030053A2 (en) 2005-02-28
CN1662519A (zh) 2005-08-31
CZ2003396A3 (cs) 2003-05-14
IL153988A0 (en) 2003-07-31
IS6693A (is) 2003-01-20
EA200300180A1 (ru) 2003-06-26
PL364439A1 (en) 2004-12-13
NO20030243D0 (no) 2003-01-17
BR0113011A (pt) 2003-07-01
HUP0302778A3 (en) 2005-02-28
AR032358A1 (es) 2003-11-05
DE60110914D1 (de) 2005-06-23
PT1301502E (pt) 2005-09-30

Similar Documents

Publication Publication Date Title
JP4230919B2 (ja) ６−フルオロビシクロ［３．１．０］ヘキサン誘導体
ZA200300514B (en) Novel compounds and their use as glycine transport inhibitors.
JP2011079801A (ja) フルオレン化合物及びその医薬用途
PT1565429E (pt) Derivados de diaril-ureído e sua utilização médica
CH683996A5 (fr) Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
KR100925900B1 (ko) 아미노산 유도체
AU2001281740A1 (en) Novel compounds and their use as glycine transport inhibitors
US20080234370A1 (en) Calcilytic Compounds
AU764746B2 (en) Calcilytic compounds
US5149714A (en) Antidepressants
US5641785A (en) Oxazoloquinolinone derivatives, their preparation and their therapeutic application as inhibitors of monoamine oxidase
US4564641A (en) Substituted 1-oxo-2-phenyl-2-(2-alkylaminoethyl)-1,2,3,4-tetrahydronaphthalenes, their preparation and their use
JP3727791B2 (ja) 二環式［３．１．０］ヘキサン及び関連化合物
US3903165A (en) Ethynylaryl amines and processes for their preparation
JP2004339199A (ja) グループｉｉメタボトロピックグルタミン酸受容体拮抗薬
CZ348595A3 (en) Pharmacologically active enantiomers, process of their preparation, intermediates of the process and their use
JP2006241158A (ja) アルファ−２−デルタリガンドを含む併用薬
WO2009101812A1 (ja) グルタミン酸トランスポーター阻害剤
JPH10512890A (ja) ２−アリール−２−アルキル−ω−アルキルアミノ−アルカンニトリルのラセミ化合物分割法